(S (S (VP (VB Aim))) (: :) (S (VP (TO To) (VP (VB review) (SBAR (WHADVP (WRB how)) (S (NP (NN machine) (NN learning) (PRN (-LRB- -LRB-) (NP (NN ML)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN applied) (PP (IN to) (NP (NN imaging) (NNS biomarkers))) (PP (IN in) (NP (NN neuro) (HYPH -) (NN oncology))) (, ,) (PP (IN in) (NP (ADJP (JJ particular) (PP (IN for) (NP (NN diagnosis) (, ,) (NN prognosis) (, ,) (CC and) (NN treatment)))) (NN response) (NN monitoring)))))))))) (. .))
(FRAG (NP (NNS Materials) (CC and) (NNS Methods)) (: :) (S (NP (DT The) (NML (NNP PubMed) (CC and) (NNP MEDLINE)) (NNS databases)) (VP (VBD were) (VP (VBN searched) (PP (IN for) (NP (NP (NNS articles)) (VP (VBN published) (PP (IN before) (NP (NNP September) (CD 2018))) (S (VP (VBG using) (NP (JJ relevant) (NN search) (NNS terms)))))))))) (. .))
(S (NP (DT The) (NN search) (NN strategy)) (VP (VBD focused) (PP (IN on) (NP (NNS articles))) (S (VP (VBG applying) (NP (NNP ML)) (PP (IN to) (NP (NML (JJ high) (HYPH -) (NN grade)) (NN glioma) (NNS biomarkers))) (PP (IN for) (NP (NP (NN treatment) (NN response)) (NP (NN monitoring) (, ,) (NN prognosis) (, ,) (CC and) (NN prediction))))))) (. .))
(NP (NP (NNS Results)) (: :) (S (S (NP (JJ Magnetic) (NN resonance) (NN imaging) (PRN (-LRB- -LRB-) (NP (NN MRI)) (-RRB- -RRB-))) (VP (VBZ is) (ADVP (RB typically)) (VP (VBN used) (PP (IN throughout) (NP (DT the) (JJ patient) (NN pathway))) (SBAR (IN because) (S (NP (JJ routine) (JJ structural) (NN imaging)) (VP (VBZ provides) (NP (JJ detailed) (ADJP (JJ anatomical) (CC and) (JJ pathological)) (NN information)))))))) (CC and) (S (NP (JJ advanced) (NNS techniques)) (VP (VBP provide) (NP (JJ additional) (JJ physiological) (NN detail))))) (. .))
(S (S (VP (VBG Using) (NP (ADJP (RB carefully) (VBN chosen)) (NN image) (NNS features)))) (, ,) (NP (NNP ML)) (VP (VBZ is) (ADVP (RB frequently)) (VP (VBN used) (S (VP (TO to) (VP (VB allow) (NP (JJ accurate) (NN classification)) (PP (IN in) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS scenarios)))))))))) (. .))
(S (PP (RB Rather) (IN than) (S (VP (VBG being) (VP (VBN chosen) (PP (IN by) (NP (JJ human) (NN selection))))))) (, ,) (NP (NNP ML)) (ADVP (RB also)) (VP (VBZ enables) (NP (NN image) (NNS features)) (S (VP (TO to) (VP (VB be) (VP (VBN identified) (PP (IN by) (NP (DT an) (NN algorithm)))))))) (. .))
(S (NP (JJ Much) (NN research)) (VP (VBZ is) (VP (VBN applied) (PP (IN to) (S (VP (VBG determining) (NP (NP (JJ molecular) (NNS profiles)) (, ,) (NP (JJ histological) (NN tumour) (NN grade)) (, ,) (CC and) (NP (NN prognosis))) (S (VP (VBG using) (NP (NP (NP (NN MRI) (NNS images)) (VP (VBN acquired) (PP (IN at) (NP (DT the) (NN time))))) (SBAR (WHADVP (WDT that)) (S (NP (NNS patients)) (ADVP (RB first)) (ADJP (JJ present) (PP (IN with) (NP (DT a) (NN brain) (NN tumour)))))))))))))) (. .))
(SINV (VP (VBG Differentiating) (NP (DT a) (NN treatment) (NN response)) (PP (IN from) (NP (NP (DT a) (JJ post-treatment-related) (NN effect)) (VP (VBG using) (NP (NN imaging)))))) (VP (VBZ is) (UCP (ADJP (RB clinically) (JJ important)) (CC and) (ADVP (RB also)))) (NP (NP (DT an) (NN area)) (PP (IN of) (NP (NP (JJ active) (NN study)) (-LRB- -LRB-) (VP (VBN described) (ADVP (RB here)) (PP (IN in) (NP (NP (CD one)) (PP (IN of) (NP (NP (CD two) (NML (JJ Special) (NN Issue)) (NNS publications)) (VP (VBN dedicated) (PP (IN to) (NP (NP (DT the) (NN application)) (PP (IN of) (NP (NNP ML))))) (PP (IN in) (NP (NN glioma) (NN imaging))))))))) (-RRB- -RRB-)))) (. .))
(FRAG (NP (NN Conclusion)) (: :) (S (SBAR (IN Although) (S (VP (VBG pioneering)))) (, ,) (NP (NP (JJS most)) (PP (IN of) (NP (DT the) (NN evidence)))) (VP (VBZ is) (UCP (PP (IN of) (NP (DT a) (JJ low) (NN level))) (, ,) (S (VP (VBG having) (VP (VBN been) (VP (VBN obtained) (ADVP (RB retrospectively)))))) (CC and) (PP (IN in) (NP (JJ single) (NNS centres)))))) (. .))
(S (NP (NP (NNS Studies)) (VP (VBG applying) (NP (NNP ML)) (S (VP (TO to) (VP (VB build) (NP (NML (NN neuro) (HYPH -) (NN oncology)) (NN monitoring) (NN biomarker) (NNS models))))))) (VP (VBP have) (ADVP (RB yet)) (S (VP (TO to) (VP (VB show) (NP (DT an) (JJ overall) (NN advantage)) (PP (IN over) (S (NP (DT those)) (VP (VBG using) (NP (JJ traditional) (JJ statistical) (NNS methods))))))))) (. .))
(S (S (NP (NP (NN Development) (CC and) (NN validation)) (PP (IN of) (NP (NNP ML) (NNS models)))) (VP (VBD applied) (PP (IN to) (NP (NP (NN neuro) (HYPH -) (NN oncology)) (SBAR (S (VP (VBP require) (NP (JJ large) (, ,) (ADJP (RB well) (HYPH -) (VBN annotated)) (NNS datasets))))))))) (, ,) (CC and) (S (ADVP (RB therefore)) (NP (JJ multidisciplinary) (CC and) (JJ multi-centre) (NNS collaborations)) (VP (VBP are) (ADJP (JJ necessary)))) (. .))
